Characterization of the single-chain Fv-Fc antibody MBP10 produced in Arabidopsis alg3 mutant seeds

[1]  Renate Kunert,et al.  In Planta Protein Sialylation through Overexpression of the Respective Mammalian Pathway , 2010, The Journal of Biological Chemistry.

[2]  R. Kunert,et al.  Improved Virus Neutralization by Plant-produced Anti-HIV Antibodies with a Homogeneous β1,4-Galactosylated N-Glycan Profile* , 2009, The Journal of Biological Chemistry.

[3]  A. Heck.  Native mass spectrometry: a bridge between interactomics and structural biology , 2008, Nature Methods.

[4]  G. Rouwendal,et al.  Identification of the Gene Encoding the α1,3-Mannosyltransferase (ALG3) in Arabidopsis and Characterization of Downstream N-Glycan Processing[W] , 2008, The Plant Cell Online.

[5]  G. Stiegler,et al.  Generation of glyco-engineered Nicotiana benthamiana for the production of monoclonal antibodies with a homogeneous human-like N-glycan structure. , 2008, Plant biotechnology journal.

[6]  M. Van Montagu,et al.  Aberrant localization and underglycosylation of highly accumulating single-chain Fv-Fc antibodies in transgenic Arabidopsis seeds , 2007, Proceedings of the National Academy of Sciences.

[7]  David Passmore,et al.  Glycan optimization of a human monoclonal antibody in the aquatic plant Lemna minor , 2006, Nature Biotechnology.

[8]  Albert J R Heck,et al.  Improving the performance of a quadrupole time-of-flight instrument for macromolecular mass spectrometry. , 2006, Analytical chemistry.

[9]  R. Van Ree,et al.  An antibody produced in tobacco expressing a hybrid β-1,4-galactosyltransferase is essentially devoid of plant carbohydrate epitopes , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[10]  R. Reski,et al.  Glyco-engineering of moss lacking plant-specific sugar residues. , 2005, Plant biology.

[11]  J. Stadlmann,et al.  Molecular basis of N-acetylglucosaminyltransferase I deficiency in Arabidopsis thaliana plants lacking complex N-glycans. , 2005, The Biochemical journal.

[12]  W. Hemmer,et al.  Specificity of IgG and IgE antibodies against plant and insect glycoprotein glycans determined with artificial glycoforms of human transferrin. , 2004, Glycobiology.

[13]  P. Lerouge,et al.  Monoclonal C5-1 antibody produced in transgenic alfalfa plants exhibits a N-glycosylation that is homogenous and suitable for glyco-engineering into human-compatible structures. , 2003, Plant biotechnology journal.

[14]  R. Dwek,et al.  Function and glycosylation of plant-derived antiviral monoclonal antibody , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Y. Kimura,et al.  Plant cultured cells expressing human beta1,4-galactosyltransferase secrete glycoproteins with galactose-extended N-linked glycans. , 2003, Glycobiology.

[16]  Y. Kimura,et al.  In vivo conversion of a glycan to human compatible type by transformed tobacco cells. , 2001, Biochemical and biophysical research communications.

[17]  G. Giddings.  Transgenic plants as protein factories. , 2001, Current opinion in biotechnology.

[18]  A. Depicker,et al.  Production of antibodies and antibody fragments in plants. , 2001, Vaccine.

[19]  P. Lerouge,et al.  Galactose-extended glycans of antibodies produced by transgenic plants , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[20]  S. Schillberg,et al.  Antibody production by molecular farming in plants. , 2000, Journal of biological regulators and homeostatic agents.

[21]  Rainer Fischer,et al.  Cereal crops as viable production and storage systems for pharmaceutical scFv antibodies , 2000, Plant Molecular Biology.

[22]  J. A. Carroll,et al.  High-yield production of a human therapeutic protein in tobacco chloroplasts , 2000, Nature Biotechnology.

[23]  S. Yoshida,et al.  Stable expression of human beta1,4-galactosyltransferase in plant cells modifies N-linked glycosylation patterns. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[24]  P. Lerouge,et al.  The protein N-glycosylation in plants , 1998 .

[25]  S L Morrison,et al.  Effect of C2-associated carbohydrate structure on Ig effector function: studies with chimeric mouse-human IgG1 antibodies in glycosylation mutants of Chinese hamster ovary cells. , 1998, Journal of immunology.

[26]  A. von Schaewen,et al.  Isolation of a Mutant Arabidopsis Plant That Lacks N-Acetyl Glucosaminyl Transferase I and Is Unable to Synthesize Golgi-Modified Complex N-Linked Glycans , 1993, Plant physiology.

[27]  R. Fischer,et al.  Molecular farming of pharmaceutical proteins , 2004, Transgenic Research.

[28]  F. Reck,et al.  Use of synthetic oligosaccharide substrate analogs to map the active sites of N-acetylglucosaminyltransferases I and II. , 2003, Methods in enzymology.

[29]  Y. Kimura.  Expression of human b1,4-galactosyltransferase gene modifies N- glycosylation pattern in tobacco BY2 cells. , 1999 .